Columbia University Medical Center Herbert Irving Pavilion — New York, New York

Public research footprint of Columbia University Medical Center Herbert Irving Pavilion, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype · Renal Cell Carcinoma · Solid Tumors With Published Evidence of Anti-tumor Activity With… · Squamous Cell Carcinoma of the Head and Neck

Recently updated registry entries

NCT06486441 — Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants… (Active Not Recruiting)
NCT06952660 — Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical… (Recruiting)
NCT07174583 — A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Columbia University Medical Center Herbert Irving Pavilion?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.